Premium
Cytolysin‐positive Enterococcus faecalis is not increased in patients with non‐alcoholic steatohepatitis
Author(s) -
Lang Sonja,
Demir Münevver,
Duan Yi,
Martin Anna,
Schnabl Bernd
Publication year - 2020
Publication title -
liver international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.873
H-Index - 110
eISSN - 1478-3231
pISSN - 1478-3223
DOI - 10.1111/liv.14377
Subject(s) - cytolysin , alcoholic hepatitis , fatty liver , medicine , alcoholic liver disease , steatohepatitis , disease , enterococcus faecalis , liver disease , dysbiosis , immunology , gastroenterology , biology , cirrhosis , virulence , bacteria , gene , biochemistry , genetics , staphylococcus aureus
Several studies show associations between gut bacterial dysbiosis and chronic liver diseases, but causative mechanisms are largely unclear. We recently identified cytolysin, a bacterial exotoxin expressed and secreted by Enterococcus faecalis to cause liver damage in the setting of alcohol‐related liver disease. Cytolysin was increased and highly correlated with liver disease severity and mortality in alcoholic hepatitis patients. In this study, we investigated if faecal cytolysin‐positivity can be linked to non‐alcoholic fatty liver disease, a highly prevalent disease where new biomarkers and treatment targets are urgently needed. In contrast to what we observed in alcoholic hepatitis, only seven out of 96 non‐alcoholic fatty liver disease patients were cytolysin‐positive, and these patients did not have increased liver disease activity compared with cytolysin‐negative patients. These results indicate that the association of cytolysin carriage with worse clinical outcome might be specific for alcoholic hepatitis.